Disclosed herein are formulations of dexamethasone or a prodrug thereof suitable for delivery by ocular iontophoresis and methods of use thereof.

FIELD: medicine, pharmaceutics.SUBSTANCE: invention refers to medicine, namely to ophthalmology, and aims at treating a wide range of inflammatory ophthalmic diseases: bacterial, allergic, infectious allergic: conjunctivitis, blepharitis, keratitis and others. The eye drops contain a sulphanyl amide preparation, dexamethasone and water. The sulphanyl amide preparation is presented by sodium sulphacyl sodium. Additionally, the drops contain boric acid and hydroxypropyl methyl cellulose in the fol...

FIELD: medicine, pharmaceutics.SUBSTANCE: invention refers to eye drops that contain 1-3 wt % of taurine, 0.01-0.1 wt % of dexamethasone, 0.4-0.6 wt % of boric acid, 0.4-0.6 wt % of hydroxypropyl methyl cellulose and water. The eye drops aim at treating various eye diseases related to metabolic disturbance in eye tissues, and inflammatory injury of an eye surface.EFFECT: higher therapeutic efficacy of the eye drops.3 ex

The present invention provides a pharmaceutical composition for topical administration comprising vancomycin or its pharmaceutically acceptable salt and dexamethasone phosphate or its pharmaceutically acceptable salt in a specific weight ratio. The pharmaceutical composition of the present invention may be formulated into a reconstitutable formulation form which provides rapid reconstitution thereby being able to obtain a transparent solution without precipitation and/or gelation. And also the r...

A method of treating newly diagnosed multiple myeloma, which comprises administering to a patient having newly diagnosed multiple myeloma: (a) about 1 to about 50 5 mg per day of a compound 3-(4-amino-l-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione, or a pharmaceutically acceptable salt, solvate or stereoisomer thereof and (b) a therapeutically effective amount of dexamethasone. C:\poi\word\SPEC-986217[1].docx